PROTEON THERAPEUTICS INC - COM (PRTO)

CUSIP: 74371L109

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
8,954,587
Share change
-119,183
Total reported value
$69,243,000
Price per share
$7.74
Number of holders
43
Value change
-$1,439,912
Number of buys
15
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 74371L109?
CUSIP 74371L109 identifies PRTO - PROTEON THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTEON THERAPEUTICS INC - COM (PRTO) as of Q1 2016

As of 31 Mar 2016, PROTEON THERAPEUTICS INC - COM (PRTO) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,954,587 shares. The largest 10 holders included Abingworth LLP, RA CAPITAL MANAGEMENT, LLC, DEERFIELD MANAGEMENT CO, MPM ASSET MANAGEMENT LLC, FMR LLC, Deer VII & Co. Ltd., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, TIVERTON ASSET MANAGEMENT LLC, and Omega Fund Management, LLC. This page lists 43 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.